Table 1.
First author, year, reference | Country | Study description | HRP2 | PCR/other NAAT method | qPCR | co-RDT |
---|---|---|---|---|---|---|
Acquah et al. 2021 [19] | Ghana | Cross-sectional prevalence | x | x | x | |
Das et al. 2017 [12] | Myanmar, Uganda | Cross-sectional prevalence | x | x | x | x |
Druetz et al. 2020 [16] | Haiti | Cross-sectional prevalence | x | |||
Galatas et al. 2020 [20] | Mozambique | Cross-sectional prevalence | x | x | x | |
Girma et al. 2019 [21] | Ethiopia | Cross-sectional prevalence | x | x | x | |
Hofmann et al. 2018 [14] | PNG | Cross-sectional prevalence | x | x | x | |
Landier et al. 2018 [13] | Myanmar | Cross-sectional prevalence | x | x | x | x |
Liu et al. 2019 [22] | Myanmar | Cross-sectional prevalence | x | x | ||
Manjurano et al. 2021 [23] | Tanzania | Cross-sectional prevalence | x | x | ||
Mwesigwa et al. 2019 [24] | The Gambia | Cross-sectional prevalence | x | |||
Owalla et al. 2020 [25] | Uganda | Cross-sectional prevalence, Clinical diagnosis | x | x | ||
Yeung et al. 2020 [15] | Cambodia | Cross-sectional prevalence, Active case detection | x | x | ||
Hartley et al. 2020 [26] | Tanzania | Clinical diagnosis | x | x | ||
Hofmann et al. 2019 [27] | Tanzania | Clinical diagnosis | x | x | x | |
Plucinski et al. 2017 [28] | Angola | Clinical diagnosis | x | x | ||
Briand et al. 2020 [29] | Benin | Pregnant women | x | |||
Unwin et al. 2020 [30] | Indonesia | Pregnant women | x | x | ||
Vásquez et al. 2018 [31] | Colombia | Pregnant women | x | x | ||
Vásquez et al. 2020 [32] | Colombia | Pregnant women | x | x | x | |
Unpublished studies | ||||||
Bridges et al. [10] | Zambia | Cross-sectional prevalence, Active case detection | x | x | ||
Saad et al. [11] | Cambodia | Cross-sectional prevalence, Active case detection | x | x | ||
Bennett et al. [9] | Laos | Cross-sectional prevalence, Active case detection | x | x |
The four columns to the right show which other diagnostics were used in each study